Adjuvant treatment of post-menopausal women w/ hormone receptor-positive early breast cancer. 1st-line treatment of post-menopausal women w/ hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer. Treatment of advanced breast cancer in post-menopausal women w/ disease progression following tamoxifen therapy. (Indication)